GURUFOCUS.COM » STOCK LIST » Financial Services » Insurance » Marsh & McLennan Companies Inc (NYSE:MMC) » Definitions » Sloan Ratio %
中文

Marsh & McLennan (Marsh & McLennan) Sloan Ratio % : 2.19% (As of Mar. 2024)


View and export this data going back to 1969. Start your Free Trial

What is Marsh & McLennan Sloan Ratio %?

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

Marsh & McLennan's Sloan Ratio for the quarter that ended in Mar. 2024 was 2.19%.

As of Mar. 2024, Marsh & McLennan has a Sloan Ratio of 2.19%, indicating the company is in the safe zone and there is no funny business with accruals.


Marsh & McLennan Sloan Ratio % Historical Data

The historical data trend for Marsh & McLennan's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Marsh & McLennan Sloan Ratio % Chart

Marsh & McLennan Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sloan Ratio %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.04 -1.73 2.30 0.99 1.91

Marsh & McLennan Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Sloan Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.69 1.77 1.91 1.91 2.19

Competitive Comparison of Marsh & McLennan's Sloan Ratio %

For the Insurance Brokers subindustry, Marsh & McLennan's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Marsh & McLennan's Sloan Ratio % Distribution in the Insurance Industry

For the Insurance industry and Financial Services sector, Marsh & McLennan's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where Marsh & McLennan's Sloan Ratio % falls into.



Marsh & McLennan Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

Marsh & McLennan's Sloan Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Sloan Ratio=(Net Income (A: Dec. 2023 )-Cash Flow from Operations (A: Dec. 2023 )
-Cash Flow from Investing (A: Dec. 2023 ))/Total Assets (A: Dec. 2023 )
=(3756-4258
--1417)/48030
=1.91%

Marsh & McLennan's Sloan Ratio for the quarter that ended in Mar. 2024 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Mar. 2024 )
=(3921-4296
--1417)/47572
=2.19%

Marsh & McLennan's Net Income for the trailing twelve months (TTM) ended in Mar. 2024 was 1035 (Jun. 2023 ) + 730 (Sep. 2023 ) + 756 (Dec. 2023 ) + 1400 (Mar. 2024 ) = $3,921 Mil.
Marsh & McLennan's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2024 was 1484 (Jun. 2023 ) + 1810 (Sep. 2023 ) + 1783 (Dec. 2023 ) + -781 (Mar. 2024 ) = $4,296 Mil.
Marsh & McLennan's Cash Flow from Investing for the trailing twelve months (TTM) ended in Mar. 2024 was -133 (Jun. 2023 ) + -442 (Sep. 2023 ) + -474 (Dec. 2023 ) + -368 (Mar. 2024 ) = $-1,417 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Marsh & McLennan  (NYSE:MMC) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Mar. 2024, Marsh & McLennan has a Sloan Ratio of 2.19%, indicating the company is in the safe zone and there is no funny business with accruals.


Marsh & McLennan Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of Marsh & McLennan's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Marsh & McLennan (Marsh & McLennan) Business Description

Address
1166 Avenue of the Americas, New York, NY, USA, 10036-2774
Marsh McLennan is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital. The company operates through two main segments: risk and insurance services and consulting. In risk and insurance services, the firm offers services via Marsh (an insurance broker) and Guy Carpenter (a risk and reinsurance specialist). The consulting division comprises Mercer (a provider of human resource services) and Oliver Wyman (a management and economic consultancy). About half of its revenue is generated outside the U.S.
Executives
Oscar Fanjul director C/O OMEGA CAPITAL, S.L., PASEO DE LA CASTELLANA, 28, MADRID U3 28046
John Jude Jones officer: Chief Marketing Officer 1166 AVENUE OF THE AMERICAS, NEW YORK NY 10036
Dean Michael Klisura officer: President & CEO, Guy Carpenter 1166 AVENUE OF THE AMERICAS, NEW YORK NY 10036
Steven A Mills director IBM CORPORATION, 294 ROUTE 100, SOMERS NY 10589
Mark C Mcgivney officer: Chief Financial Officer
Judith Hartmann director 1166 AVENUE OF THE AMERICAS, NEW YORK NY 10036
Ray G Young director 77 WEST WACKER DR., SUITE 4600, CHICAGO IL 60601
Stacy Mills officer: Vice President and Controller C/O MARSH & MCLENNAN COMPANIES, INC., 1166 AVENENUE OF THE AMERICAS, NEW YORK NY 11102
Paul Beswick officer: SVP, Chief Information Officer 1166 AVENUE OF THE AMERICAS, NEW YORK NY 10036
Martin South officer: President & CEO, Marsh 1166 AVENUE OF THE AMERICAS, NEW YORK NY 10036
Martine Ferland officer: President and CEO, Mercer C/O MARSH & MCLENNAN COMPANIES, INC., 1166 AVENUE OF THE AMERICAS, NEW YORK NY 10036
Katherine Brennan officer: SVP and General Counsel 1166 AVENUE OF THE AMERICAS, 1166 AVENUE OF THE AMERICAS, NEW YORK NY 10036
Daniel S Glaser officer: Chairman & CEO, Marsh C/O MARSH & MCLENNAN COMPANIES, INC., 1166 AVENUE OF THE AMERICAS, NEW YORK NY 10036
Hafize Gaye Erkan director 727 FIFTH AVENUE, NEW YORK NY 10022
Marc D Oken director C/O FALFURRIAS CAPITAL PARTNERS, 100 N. TRYON STREET, SUITE 5120, CHARLOTTE NC 28202